Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient
Authors:
- Jeff T EdwardsJEJeff T Edwards
- James K HambyJHJames K Hamby
- Neil K WorrallNWNeil K Worrall
- 1 May 2003
- journal article
- case report
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 75 (5) , 1622-1624
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operationsThe Journal of Thoracic and Cardiovascular Surgery, 2001
- A Synopsis of the Clinical Uses of ArgatrobanJournal of Thrombosis and Thrombolysis, 2001
- Clinical experience of argatroban for anticoagulation in cardiovascular surgeryThe Japanese Journal of Thoracic and Cardiovascular Surgery, 2000
- Emergent Cardiopulmonary Bypass in Five Patients with Heparin-induced Thrombocytopenia Type II Employing Recombinant HirudinAnesthesiology, 1998
- Prevalence of Heparin-Associated Antibodies Without Thrombosis in Patients Undergoing Cardiopulmonary Bypass SurgeryCirculation, 1997
- AnnotationBritish Journal of Haematology, 1995
- Complications From Heparin-induced Thrombocytopenia in Patients Undergoing Cardiopulmonary BypassChest, 1993